SECTOR : Biotech
ENTRY DATE : 2018
BUSINESS : Venture Capital
WEB : antabio.com


ANTABIO

Fighting drug resistant infections

Antabio is a Toulouse-based private biotech company developing novel antibacterials targeting drug-resistant pathogens that are deemed a critical priority by the WHO.


PRESS RELEASE :

12/07/2018 ANTABIO Completes €12.5m Series A
Read

Search